Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$283K Sell
781
-124
-14% -$42.4K 0.03% 282
2026
Q1
$318K Sell
905
-72
-7% -$25.7K 0.04% 260
2025
Q4
$320K Sell
977
-43
-4% -$13.6K 0.04% 258
2025
Q3
$288K Sell
1,020
-413
-29% -$120K 0.04% 262
2025
Q2
$400K Sell
1,433
-33
-2% -$9.35K 0.06% 212
2025
Q1
$457K Buy
1,466
+356
+32% +$105K 0.08% 204
2024
Q4
$289K Sell
1,110
-1,223
-52% -$363K 0.05% 240
2024
Q3
$752K Buy
2,333
+143
+7% +$46.8K 0.13% 162
2024
Q2
$684K Buy
2,190
+165
+8% +$48.5K 0.13% 161
2024
Q1
$576K Buy
+2,025
New +$593K 0.11% 181
2023
Q3
Sell
-1,651
Closed -$367K 230
2023
Q2
$367K Buy
1,651
+123
+8% +$28.5K 0.1% 184
2023
Q1
$369K Buy
+1,528
New +$375K 0.11% 184
2021
Q3
Sell
-6,262
Closed -$1.53M 212
2021
Q2
$1.53M Sell
6,262
-204
-3% -$50.2K 0.49% 57
2021
Q1
$1.61M Buy
6,466
+78
+1% +$18.6K 0.57% 47
2020
Q4
$1.47M Buy
6,388
+250
+4% +$57.6K 0.55% 46
2020
Q3
$1.56M Sell
6,138
-3,882
-39% -$962K 0.67% 40
2020
Q2
$2.36M Buy
10,020
+887
+10% +$202K 1.22% 20
2020
Q1
$1.85M Sell
9,133
-678
-7% -$148K 1.13% 20
2019
Q4
$2.37M Sell
9,811
-1,092
-10% -$241K 1.08% 24
2019
Q3
$2.11M Buy
10,903
+1,200
+12% +$230K 1.19% 25
2019
Q2
$1.79M Buy
9,703
+705
+8% +$126K 0.99% 29
2019
Q1
$1.71M Buy
8,998
+574
+7% +$110K 0.98% 35
2018
Q4
$1.64M Buy
8,424
+6,622
+367% +$1.29M 1.09% 35
2018
Q3
$374K Buy
1,802
+52
+3% +$10.2K 0.21% 80
2018
Q2
$323K Buy
1,750
+1
+0.1% +$177 0.2% 84
2018
Q1
$298K Buy
1,749
+89
+5% +$16.3K 0.19% 90
2017
Q4
$289K Sell
1,660
-273
-14% -$48.3K 0.19% 83
2017
Q3
$360K Buy
1,933
+28
+1% +$4.96K 0.23% 80
2017
Q2
$328K Sell
1,905
-50
-3% -$8.13K 0.23% 87
2017
Q1
$321K Sell
1,955
-13,005
-87% -$2.16M 0.24% 83
2016
Q4
$2.19M Buy
+14,960
New +$2.25M 1.84% 15

Other funds holding AMGN

JT Stratford LLC's AMGN Position: Q2 2026 in Review

JT Stratford LLC reduced its Amgen (AMGN) stake by 14% in Q2 2026, selling an estimated $42.4K and leaving 781 shares worth $283K. The position accounts for 0.03% of the portfolio, ranked #282.

JT Stratford LLC first reported a position in AMGN in Q4 2016 and has held it in 31 quarters since. The position peaked at $2.37M in Q4 2019. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • JT Stratford LLC held 781 shares of Amgen worth $283K as of Q2 2026.
  • JT Stratford LLC sold 124 Amgen shares in Q2 2026, an estimated $42.4K.
  • Amgen made up 0.03% of JT Stratford LLC's portfolio in Q2 2026, its #282 holding.
  • JT Stratford LLC first reported a position in Amgen in Q4 2016 and has held it in 31 quarters since.
  • JT Stratford LLC's Amgen position peaked at $2.37M in Q4 2019.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on JT Stratford LLC's 13F filing for Q2 2026, filed 14 Aug 2026.